While cancer patients can experience ghosting, and cancer ghosting is real, it is possible to revisit relationships to avoid ...

Dave Nitsche, a nonsmoker and athlete, was diagnosed with stage 4 lung cancer after vision loss led to the discovery of ...

Previvorship requires inclusive representation on social media, covering scientific, emotional, and social aspects of ...

The artwork of Gail Durant, winner of the annual CURE Calendar Contest, captured the heart of her family’s connection to home ...

Advances in targeted therapies, especially those targeting KRAS mutations, and cancer vaccines show promise in pancreatic ...

Bezuclastinib plus Sutent significantly improved progression-free survival and objective response rates in Gleevec-resistant ...

Following the 2025 European Society for Medical Oncology (ESMO) Annual Congress held in Berlin, Germany, we sat down with leading experts in oncology to discuss the latest advances in bladder cancer ...

A thymoma diagnosis can feel overwhelming, but it is important to know that many patients respond well to treatment.

Throughout October, CURE highlighted research developments and evolving treatment strategies that continue to shape cancer ...

Stage 2 cervical cancer is classified into 2A and 2B, based on tumor spread and size, affecting treatment decisions.

The FDA approved Darzalex Faspro for the treatment of adults with high-risk smoldering multiple myeloma. The U.S. Food and ...

Amtagvi monotherapy achieved a 25.6% objective response rate and 71.8% disease control rate in NSCLC patients without ...